● The company has a good ESG score relative to its sector, according to MSCI.
Strengths
● The group's high margin levels account for strong profits.
● With a P/E ratio at 11.4 for the current year and 9.78 for next year, earnings multiples are highly attractive compared with competitors.
● With regards to fundamentals, the enterprise value to sales ratio is at 0.42 for the current period. Therefore, the company is undervalued.
● The company is one of the best yield companies with high dividend expectations.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
● The company's earnings growth outlook lacks momentum and is a weakness.
● The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
● The group shows a rather high level of debt in proportion to its EBITDA.
● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
● Revenue estimates are regularly revised downwards for the current and coming years.
● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
● For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
● Most analysts recommend that the stock should be sold or reduced.
● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
● The average consensus view of analysts covering the stock has deteriorated over the past four months.
● Over the past twelve months, analysts' opinions have been revised negatively.
